Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

<ul>
<li>MiMedx is a wound care and therapeutic biologics company, developing and distributing allografts.</li>
<li>The company derives its products from human placental tissues processed using the Purion technology.</li>
<li>MiMedx differentiates itself in the regenerative medicine market through the substantial library of supportive research for its products.</li>
</ul>


MiMedx is a wound care and therapeutic biologics company, developing and distributing allografts.
The company derives its products from human placental tissues processed using the Purion technology.
MiMedx differentiates itself in the regenerative medicine market through the substantial library of supportive research for its products.


United States

MiMedx Group Inc. operates as a medical device company. The Company focuses on biomaterials for soft tissue repair, such as tendons, ligaments, and cartilage, as well as other biomaterial based products for other medical applications. MiMedx Group serves the medical industry worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

MiMedx Group (MDXG US)

MDXG: MACs Give Credit for Efficacy

MiMedx is a wound care and therapeutic biologics company, developing and distributing allografts. The company derives its products from human...

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)